1525-1470/asset/PDE_left.gif?v=1&s=1299ee0db2f6355a4a3b185c5ee6579c15b0e598)
1525-1470/asset/PDE_right.gif?v=1&s=b6dee6f6511f21d924e3c0b0005944e0168ab2c0)
BRIEF REPORT
Severe Dyshidrotic Eczema after Intravenous Immunoglobulin Therapy for Kawasaki Syndrome
Article first published online: 3 FEB 2012
DOI: 10.1111/j.1525-1470.2011.01717.x
© 2012 Wiley Periodicals, Inc.
Additional Information
How to Cite
Shiraishi, T. and Yamamoto, T. (2013), Severe Dyshidrotic Eczema after Intravenous Immunoglobulin Therapy for Kawasaki Syndrome. Pediatric Dermatology, 30: e30–e31. doi: 10.1111/j.1525-1470.2011.01717.x
Publication History
- Issue published online: 26 APR 2013
- Article first published online: 3 FEB 2012
- Abstract
- Article
- References
- Cited By
Abstract: Dyshidrotic eczema is one of the rare cutaneous adverse effects of intravenous immunoglobulin therapy, usually seen in adults. We herein report the first pediatric case of severe dyshidrotic eczema occurring after intravenous immunoglobulin therapy for Kawasaki syndrome.